<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0715">
 <label>143</label>
 <mixed-citation publication-type="other" id="h0715">A Shamsi, T. Mohammad, S. Anwar, M.F. Al Ajmi, A. Hussain, M.T. Rehman, A. Islam, M.I. Hassan, Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy, Biosci. Rep. 40 (2020) BSR20201256, doi: 10.1042/BSR20201256.</mixed-citation>
</ref>
